Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chronic Back Pain Clinical Trials

A listing of Chronic Back Pain medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (10) clinical trials

This study will be a Phase III, placebo-controlled, multicenter study with an enriched-enrollment withdrawal design to evaluate the efficacy and safety of CAM2038 in opioid-experienced subjects with moderate to severe CLBP that requires continuous, around-the-clock (ATC) opioid treatment. The study will comprise 5 phases: a Screening Phase (up to 2 ...

Phase

Phase III study in patients with a Recent History of Moderate to Severe Chronic Low Back Pain currently treated with Opioids.

Phase

To determine the analgesic efficacy of XXXXX (BID) in patients with moderate-to-severe chronic low back pain requiring opioid analgesia for an extended period of time.

Phase

This study is being conducted to evaluate the safety and effectiveness of a study drug for the treatment of chronic low back pain. If you qualify for participation in this study, your participation would last approximately 25 weeks and you would be required to make about 20 office visits to ...

Phase

SUMMIT Phase 3 Program The SUMMIT Phase 3 program for NKTR-181 includes two enriched-enrollment, randomized withdrawal (EERW) efficacy and safety studies and a 52-week long-term safety study (SUMMIT-LTS). Enrollment has begun in the first Phase 3 efficacy study (SUMMIT-07) which will evaluate NKTR-181 versus placebo in opioid-naïve patients with chronic ...

Phase

Medial Branch Block vs Para-spinal Muscle Injection in Patients With Non-specific Chronic Low Back Pain

Pain relief following medial branch block (MBB) might be due to facet joints desensitization and/or myofascial trigger points' desensitization. Patients will be randomized to two groups. The first group receives MBB in one side and paravertebral deep intramuscular (PDI) injection in the other side of the back. Next week the ...

Phase

Hip Posterolateral Complex Strengthening in Patients With Chronic Nonspecific Low Back Pain: a Randomized Clinical Trial

Randomised clinical trial will be held in following the recommendations of the CONSORT (Consolidated Standards of Reporting Trials). Will be recruited participants of both genders, aged between 18 and 60 years, with and without chronic nonspecific low back pain for over 3 months without irradiation for lower limbs. Potential participants ...

Phase

Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain

This study will be a Phase III, placebo-controlled, multicenter study with an enriched-enrollment withdrawal design to evaluate the efficacy and safety of CAM2038 in opioid-experienced subjects with moderate to severe CLBP that requires continuous, around-the-clock (ATC) opioid treatment. The study will comprise 5 phases: a Screening Phase (up to 2 ...

Phase

Chronic Low Back Pain Randomized Controlled Trial

The study will employ a two arm parallel group stratified controlled trial. A total of 60 subjects from 18 through 64 years old with low back pain on at least half the days over the previous 6 months will be recruited by the Wilton Family YMCA to participate in the ...

Phase

D-cycloserine for the Treatment of Chronic Refractory Low Back Pain

This is a 26-week, double-blind, randomized, placebo-controlled two-arm parallel-group trial of d-cycloserine, a pharmacological treatment selected based on positive results from previous preclinical and clinical studies, for the treatment of chronic, refractory low back pain (CBP). After a 2-week screening period, individuals will be randomized to receive either 12 weeks ...

Phase